article thumbnail

Bonus Features – May 5, 2024 – Kaiser Permanente taps Innovaccer (and former CTO) for AI, report finds security flaws in Merge DICOM Toolkit, plus 18 more stories

Healthcare IT Today

It’s a big blow for Walmart, which according to Healthcare Dive initially set a goal in 2019 of opening 4,000 clinics by 2029. Products GE HealthCare announced FDA 510(k) clearance for Portrait VSM , its portable vital sign monitor.

FDA 96
article thumbnail

Monitor Improper Payments for Part C and Part D with Medicare Audit and Monitoring Software

Innovaare Compliance

annually on average between 2021 and 2029 compared to 4.4% Examples of improper payments include: Unusual quantities or administration frequency of Part B drugs; Drugs for non-FDA approved indications (e.g., In fact, spending per enrollee in MA plans is projected to grow 5.3%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

NATIONAL 14 rural senators push CMS to extend low-wage hospitals’ payment bump in FY2024 American Hospital Association voices support for telehealth expansion bill Behavioral health market to hit $262B by 2029 Biden administration moves to establish ‘guardrails’ for telehealth prescriptions CMS Officials Confirm End of PHE Nursing (..)

article thumbnail

Healthcare Reforms Under the IRA: Expanding Access to Care

Healthcare Law Blog

Drugs eligible for negotiation must be FDA-approved for at least 7 years and marketed in conformance with the Federal Food, Drug, and Cosmetic Act. Premiums for Part D plans will be subject to a premium stabilization plan under which they are capped at an increase of 6% annually through 2029. Negotiation-Eligible Drugs.

article thumbnail

World’s Largest Radiology AI Marketplace CARPL Raises $6M to Accelerate the Adoption of AI in Clinical Workflows

Healthcare IT Today

With more than 700 US FDA-approved AI applications, healthcare providers grapple with navigating the complex landscape of niche AI solutions. The global healthcare AI market is expected to cross $170 billion by 2029 , of which almost $20 billion will be in the domain of radiology.

FDA 81